Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11966361 | 0.94 | ESR2 (0.37) | ESR2PDE10APDE2A | |
| SCHEMBL10091426 | 0.86 | NOTUM (0.30) | ESR2PDE2A | |
| SCHEMBL11965811 | 0.82 | ALOX5AP (0.31) | PIM1ALOX5APFEN1 | |
| SCHEMBL11965231 | 0.82 | ESR2 (0.44) | ESR2 | |
| SCHEMBL11953551 | 0.79 | ESR2 (0.34) | ESR2PDE10AALOX5APFEN1 | |
| SCHEMBL11939217 | 0.78 | FPR2 (0.36) | ALOX5APFEN1 | |
| SCHEMBL10091411 | 0.77 | ESR2 (0.33) | ESR2 | |
| SCHEMBL11965808 | 0.77 | TRPV3 (0.39) | PIM1PDE10AALOX5APFEN1 | |
| SCHEMBL2506935 | 0.76 | HCRTR2 (0.36) | PDE10AALOX5APFEN1 | |
| SCHEMBL11943411 | 0.75 | PTGER2 (0.33) | ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | KIF23, MARK3, CCND3 | ESR2 3467/4885PIM1 2269/4885PDE10A 1946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.